(Q43033068)

English

Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.

scientific article published on 13 January 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

liver cirrhosis

0 references

chronic hepatitis C

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

object named as

O Andersen

5

0 references

author name string

E S Andersen

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Ruhwald

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

B Moessner

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

P B Christensen

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J Eugen-Olsen

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

13 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

761-766

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Acute viral hepatitis increases liver stiffness values measured by transient elastography

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1149-Y

21 January 2018

IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and function of interleukin-8 in human hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 21-year experience with major hemorrhage after percutaneous liver biopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver biopsy. Its safety and complications as seen at a liver transplant center

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21229279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-010-1149-Y

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43033068&oldid=2205758666"